Mr. Richardson leads communications including investor, media and employee relations for Inovio, a biotechnology company developing a COVID vaccine and other DNA therapies for infectious diseases and cancer.  He previously held global communications roles at Amgen and GSK.  He began his career as a writing Instructor at Temple University and was a reporter and editor at a Gannett Newspaper.